About the Authors
- Erica B. Schleifman
-
Contributed equally to this work with: Erica B. Schleifman, Rachel Tam
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Rachel Tam
-
Contributed equally to this work with: Erica B. Schleifman, Rachel Tam
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Rajesh Patel
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Alison Tsan
-
Affiliation Chemistry and Innovation Technology, Pleasanton, California, United States of America
- Teiko Sumiyoshi
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Ling Fu
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Rupal Desai
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Nancy Schoenbrunner
-
Affiliation Chemistry and Innovation Technology, Pleasanton, California, United States of America
- Thomas W. Myers
-
Affiliation Program in Core Research, Roche Molecular Systems Inc., Pleasanton, California, United States of America
- Keith Bauer
-
Affiliation Program in Core Research, Roche Molecular Systems Inc., Pleasanton, California, United States of America
- Edward Smith
-
Affiliation Program in Core Research, Roche Molecular Systems Inc., Pleasanton, California, United States of America
- Rajiv Raja
-
* E-mail: raja.rajiv@gene.com
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflicts: All studies were funded by Genentech, Inc. Erica Schleifman, Rachel Tam, Rajesh Patel, Teiko Sumiyoshi, Ling Fu, Rupal Desai, and Rajiv Raja are or were employed by Genentech, and Alison Tsan, Nancy Schoenbrunner, Thomas W. Myers, Keith Bauer, and Edward Smith are or were employed by Roche Molecular Systems Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RR RP. Performed the experiments: RT E. Schleifman RP RD. Analyzed the data: RP E. Schleifman RT TS. Contributed reagents/materials/analysis tools: RP AT RT RD LF NS TM KB E. Smith RR. Wrote the paper: E. Schleifman RT RP AT NS TM KB E. Smith RR.